To study if Vojta therapy can reduce the perinatal risk and decrease the days of hospitalization of preterm infants with Respiratory Distress Syndrome (RDS) and Bronchopulmonary Dysplasia (BPD).
All infants were assessed with the Perinatal Risk Inventory (PERI) when discharged. Two t-Student tests were carried out of mean differences for independent samples between the scores of perinatal risk and of the days of hospitalization of both groups. D statistic was calculated to determine the effect size.
Reflex Locomotion Reflex Rolling 2ª Phase
Our findings reveal significant differences between both groups, with significantly better outcome among the infants who received Vojta Therapy; infants in EG obtained lower PERI scores [p-value<0.001] and were less days in hospital [p=0.001] when compared to the CG. The effect size was large among the EG in the reduction of perinatal risk (d=0.95) and of the days in hospital (d=1.86). 
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